| abstract |
The present invention relates to a vaccine composition for preventing tuberculosis, the alpha-crystallin protein (16kDa) of Mycobacterium tuberculosis; Ag85A protein (32kDa) and ESAT-6 protein (6kDa); Ag85A protein and phosphate binding protein 1 (38 kDa); And Ag85A protein, ESAT-6 protein, and alpha-crystallin protein antigen.n n n n Tuberculosis prevention vaccine, Ag85A, ESAT-6, alpha-crystalline protein, phosphate binding protein 1 |